These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8940157)

  • 41. Conserved chromatin structure in c-myc 5'flanking DNA after viral transduction.
    Kumar S; Leffak M
    J Mol Biol; 1991 Nov; 222(1):45-57. PubMed ID: 1942068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells.
    Ishida S; Shudo K; Takada S; Koike K
    Cell Growth Differ; 1995 Mar; 6(3):229-37. PubMed ID: 7794791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products.
    Nakagoshi H; Kanei-Ishii C; Sawazaki T; Mizuguchi G; Ishii S
    Oncogene; 1992 Jun; 7(6):1233-40. PubMed ID: 1594249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of two enhancer elements downstream of the human c-myc gene.
    Mautner J; Joos S; Werner T; Eick D; Bornkamm GW; Polack A
    Nucleic Acids Res; 1995 Jan; 23(1):72-80. PubMed ID: 7870592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer.
    Hu HM; Kanda K; Zhang L; Boxer LM
    Leukemia; 2007 Apr; 21(4):747-53. PubMed ID: 17287852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The block to transcription elongation is promoter dependent in normal and Burkitt's lymphoma c-myc alleles.
    Spencer CA; LeStrange RC; Novak U; Hayward WS; Groudine M
    Genes Dev; 1990 Jan; 4(1):75-88. PubMed ID: 2307371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel DNase I hypersensitive sites in the 3'-flanking region of the human c-myc gene.
    Murphy LC; Huzel N; Davie JR
    DNA Cell Biol; 1996 Jul; 15(7):543-8. PubMed ID: 8756335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p53 binds to a constitutively nucleosome free region of the mdm2 gene.
    Xiao G; White D; Bargonetti J
    Oncogene; 1998 Mar; 16(9):1171-81. PubMed ID: 9528859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter.
    Kim HG; Miller DM
    Biochemistry; 1995 Jun; 34(25):8165-71. PubMed ID: 7794930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels.
    Postel EH; Flint SJ; Kessler DJ; Hogan ME
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8227-31. PubMed ID: 1896473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of bulk and c-myc P2 promoter-specific DNA damage by an anti-topoisomerase II agent salvicine is an early event leading to apoptosis in HL-60 cells.
    Meng L; Ding J
    FEBS Lett; 2001 Jul; 501(1):59-64. PubMed ID: 11457456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells.
    Wada RK; Seeger RC; Reynolds CP; Alloggiamento T; Yamashiro JM; Ruland C; Black AC; Rosenblatt JD
    Oncogene; 1992 Apr; 7(4):711-7. PubMed ID: 1565467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Basal and vitamin D-responsive activity of the rat osteocalcin promoter in stably transfected osteosarcoma cells: requirement of upstream sequences for control by the proximal regulatory domain.
    Frenkel B; Montecino M; Green J; Aslam F; Desai R; Banerjee C; Stein JL; Lian JB; Stein GS
    Endocrinology; 1996 Mar; 137(3):1080-88. PubMed ID: 8603577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. c-Ha-rasVal 12 oncogene-transformed NIH-3T3 fibroblasts display more decondensed nucleosomal organization than normal fibroblasts.
    Laitinen J; Sistonen L; Alitalo K; Hölttä E
    J Cell Biol; 1990 Jul; 111(1):9-17. PubMed ID: 2195041
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of topoisomerase II-mediated DNA cleavage of the c-myc gene during HL60 differentiation.
    Riou JF; Gabillot M; Riou G
    FEBS Lett; 1993 Nov; 334(3):369-72. PubMed ID: 8243649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular analysis of the human myeloperoxidase promoter region.
    Chumakov AM; Chumakova EA; Chih D; Koeffler HP
    Int J Oncol; 2000 Feb; 16(2):401-11. PubMed ID: 10639585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cis-platin responsive sequences in the human c-myc promoter.
    Spandidos DA; Zoumpourlis V; Lang JC
    Anticancer Res; 1991; 11(3):1339-42. PubMed ID: 1888169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The promoter and enhancer of the inactive chicken beta-globin gene contains precisely positioned nucleosomes.
    Buckle R; Balmer M; Yenidunya A; Allan J
    Nucleic Acids Res; 1991 Mar; 19(6):1219-26. PubMed ID: 1709485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line.
    Moberg KH; Tyndall WA; Hall DJ
    J Cell Biochem; 1992 Jun; 49(2):208-15. PubMed ID: 1400626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of nuclear protein binding to two sites in the murine c-myc promoter by intermolecular triplex formation.
    Reddoch JF; Miller DM
    Biochemistry; 1995 Jun; 34(23):7659-67. PubMed ID: 7779812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.